Beyond Achondroplasia

Growing together with Clara

December 10, 2017
by inesp.alves

Update on BioMarin´s Achondroplasia Clinical Development Program

BioMarin Pharmaceutical sent to patient organizations an update of the clinical development program for BMN-111. The current status of the achondroplasia clinical programme is described in the document below. BioMarin’s investigational therapy for achondroplasia, BMN 111, is currently under investigation … Continue reading

Translate »